AMG - HARMONY Alliance

HARMONY
Healthcare Alliance for Resourceful Medicine Offensive against Neoplasms in Hematology

HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

HARMONY Coordination Office
Institute of Biomedical Research of Salamanca (IBSAL)
Salamanca, Spain

harmonyoffice@ibsal.es
+34 678 841 121

HARMONY Communications
European Hematology Association (EHA)
The Hague
The Netherlands

communications@harmony-alliance.eu
+31 70 3020099